AFP and cancer: Despite the fact that plasma protein biomarkers are commonly used in clinical management for different cancers, such as AFP, CEA, PSA, and CA15-3 (Mazzucchelli et al., 2000; He et al., 2013), some cancer patients are not positive for these biomarkers.